Search
-
News
Join Jedd Wolchok, MD, PhD, during the June 24 edition of “MSK Science Spotlight” for a discussion on “Enabling Costimulatory Pathways as a Next Step for Cancer Immunotherapy.”
… Wednesday, June 24, 2020 Join Jedd Wolchok, MD, PhD, during the June 24 edition of “ MSK Science Spotlight ” for a discussion on “Enabling Costimulatory Pathways as a Next Step for Cancer Immunotherapy.” Dr. Wolchok serves as the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation
-
News
Moriyina Cole’s path to MSK started with a childhood in Sierra Leone, a move to Maryland when she was 15 years old, followed by time at Western Michigan University and Union Graduate College, where she received an undergraduate degree and a Master of Business Administration, respectively.
… Monday, March 28, 2022 Moriyina Cole’s path to MSK started with a childhood in Sierra Leone, a move to Maryland when she was 15 years old, followed by time at Western Michigan University and Union Graduate College, where she received an undergraduate degree and a Master of Business Administration, respectively
-
News
Analysis of long-preserved single cells on pathology slides aims to provide new clues about the genes that make breast cancer more aggressive.
… Friday, February 10, 2017 Summary A new technique that enables researchers to study single cells from older samples taken from people with breast cancer is opening the door to new findings about genetic changes that make cancer aggressive. Highlights MSK has an incredible storehouse of tumor samples
-
News
David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).
… Friday, May 1, 2009 Summary David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP). Dr. Scheinberg is a physician-scientist involved in both basic
-
News
MSK studies look at the role of RNA splicing factors in acute myeloid leukemia and melanoma.
… Wednesday, October 9, 2019 Summary Two studies looked at the role of specific RNA splicing factors in different cancers. These factors help regulate how proteins are manufactured. Manufacturing proteins is a multistep process that’s hard-coded into how our cells operate. Genes, which are made of DNA,
-
News
Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at MSK are discovering.
… Tuesday, November 5, 2024 Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at Memorial Sloan Kettering Cancer Center (MSK) are discovering
-
News
MSK is proud to return as a participant in the 4th Annual Black Health Matters Virtual Summit. Black Health Matters Virtual Summit will provide attendees a chance to interact with physicians, scientists, and advocates, including former First Lady, Michelle Obama, to address equity in all areas of health.
… Wednesday, July 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) is proud to return as a participant in the 4 th Annual Black Health Matters Virtual Summit on Saturday, July 18, from 8:30 a.m. to 6:00 p.m. COVID-19 has created new and unprecedented challenges for patients. This year’s virtual event
-
News
MSK is a founding member of the Cancer AI Alliance (CAIA), an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care. This unique alliance unites four leading NCI-designated cancer centers — MSK, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins — with technology powerhouses that include Ai2, Amazon, Deloitte, Google, Microsoft, Nvidia, and Slalom.
… Wednesday, December 24, 2025 MSK is a founding member of the Cancer AI Alliance (CAIA) , an exciting collaborative research initiative designed to accelerate development and deployment of AI models to improve cancer care. This unique alliance unites four leading NCI-designated cancer centers — MSK
-
2024 Annual Report
Learn how MSK experts are improving the detection and treatment of lung cancer, from fundamental questions of the disease biology to new screening and therapy options.
… Friday, June 6, 2025 Jen Cosgrove says her first appointment at Memorial Sloan Kettering Cancer Center (MSK) was unforgettable. “When my family and I showed up at MSK, we felt totally defeated,” she says. “We knew I had a type of lung cancer called adenocarcinoma — that was it.” As a wife and mother
-
Partnering Opportunities
May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the world.
… Friday, October 3, 2025 May is Clinical Trials Awareness Month, culminating on May 20 with International Clinical Trials Day. For institutions like ours, this is an opportunity to commemorate the importance of clinical research and the valued contributions of clinical research professionals around the